The Global Health Body Issues Warning Over Acute Lack of Obesity Medications
Less than 10% of individuals eligible to benefit from obesity jabs including Wegovy have access to them, warns the World Health Organization as it issues its first advice on the medications.
Given in excess of 1,000,000,000 individuals worldwide now living with obesity, it is advocating for more widespread and fairer access to GLP-1 medication.
According to estimates, more than two billion are projected to be living with obesity by 2030 without intervention.
"Our latest guidelines recognises that excess weight is a long-term condition that can be addressed with holistic and continuous support," stated its chief Tedros Adhanom Ghebreyesus.
Substantial prices, insufficient output, and supply-chain constraints are major hurdles to universal availability to the treatments that can aid individuals in losing considerable weight, says the agency.
Weight-Loss Drug Shortage
Even under the present most favorable scenario, the manufacturing of these medications would only suffice for around 100 million people – under 10% of the global need, as stated by the WHO.
The advice encourages governments and firms to increase availability, through strategies including patent sharing.
Exclusive production rights on a key compound – the primary component of the drug Wegovy – is set to lapse in multiple nations in 2026.
How Obesity Injections Work
These medications mimick a natural hormone to reduce digestion speed, curb appetite and increase feelings of fullness so people eat less.
People usually see weight reduction within a few weeks of beginning the once-weekly jabs.
Studies indicates users may see weight return after a year of discontinuing the treatment, because their typical appetite return.
Being carrying excess weight elevates your likelihood for developing diseases, including type 2 diabetes, heart disease, brain attack, and specific cancers.
Obesity affects people in every country and was responsible for 3.7 million fatalities worldwide in 2024, according to the WHO.